betamethasone 0.284 MG/ML / gentamicin 0.57 MG/ML Topical Spray
- RxCUI
- 1093235
- RxNorm name
- betamethasone 0.284 MG/ML / gentamicin 0.57 MG/ML Topical Spray
- Term type
- SCD
- Status
- Active
- Updated
- 2026-09-09 14:38:47
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042011
- Active start
- 042011
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
Ingredient, Strength, Base table| Ingredient | Strength | Base | Basis of strength |
|---|
| betamethasone | 0.284 MG / 1 ML | betamethasone | betamethasone |
| gentamicin | 0.57 MG / 1 ML | gentamicin | gentamicin |
Derived Ingredient Concepts#
RxNav Current And Historical NDCs#
RxNav current and historical NDC rows page 1 of 1 · 9 matching rows.
NDC11, Source, Active table| NDC11 | Source | Active |
|---|
| 11695700901 | rxnav_ndcs | yes |
| 11695700902 | rxnav_ndcs | yes |
| 11695700903 | rxnav_ndcs | yes |
| 13985056612 | rxnav_historical | |
| 13985056624 | rxnav_historical | |
| 13985056660 | rxnav_historical | |
| 14043060209 | rxnav_historical | |
| 14043060213 | rxnav_historical | |
| 14043060262 | rxnav_historical | |
UNII Substances#
UNII substance links page 1 of 1 · 0 matching rows.
No records found.
DailyMed RxNorm Mappings#
unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 4 matching rows.
Set ID, RxNorm mappings, Terms table| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|
| 290080ca-f351-48f8-a48b-bf5d40a70a8d | gentamicin sulfate 0.057 % / betamethasone valerate 0.0284 % Topical Spray [PSN] · betamethasone 0.284 MG/ML / gentamicin 0.57 MG/ML Topical Spray [SCD] · gentamicin (as gentamicin sulfate) 0.057 % / betamethasone (as betamethasone valerate) 0.0284 % Topical Spray [SY] | 3 | 7 | GENTACALM ® Topical Spray | 20240307 |
| 83e23b7f-9007-487f-b519-65fb4707fbbc | gentamicin sulfate 0.057 % / betamethasone valerate 0.0284 % Topical Spray [PSN] · betamethasone 0.284 MG/ML / gentamicin 0.57 MG/ML Topical Spray [SCD] · gentamicin (as gentamicin sulfate) 0.057 % / betamethasone (as betamethasone valerate) 0.0284 % Topical Spray [SY] | 3 | 7 | GenOne ™ Spray | 20230926 |
| f65a673e-a374-462b-a5fd-8cf1ebc9561f | gentamicin sulfate 0.057 % / betamethasone valerate 0.0284 % Topical Spray [PSN] · betamethasone 0.284 MG/ML / gentamicin 0.57 MG/ML Topical Spray [SCD] · gentamicin (as gentamicin sulfate) 0.057 % / betamethasone (as betamethasone valerate) 0.0284 % Topical Spray [SY] | 3 | 6 | GentaVed Topical Spray Gentamicin Sulfate With Betamethasone Valerate TOPICAL SPRAY | 20241202 |
| e732e591-fe4e-4fef-a9ea-ba3a0495995e | gentamicin sulfate 0.057 % / betamethasone valerate 0.0284 % Topical Spray [PSN] · betamethasone 0.284 MG/ML / gentamicin 0.57 MG/ML Topical Spray [SCD] · gentamicin (as gentamicin sulfate) 0.057 % / betamethasone (as betamethasone valerate) 0.0284 % Topical Spray [SY] | 3 | 2 | Gentamicin Sulfate With Betamethasone Valerate TOPICAL SPRAY | 20250623 |
Recently Linked DailyMed Labels#
Drug Classes#
Source, Class ID, Class table| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|
| ATC | S01AA | Antibiotics | ATC1-4 | | gentamicin |
| ATC | S03AA | Antiinfectives | ATC1-4 | | gentamicin |
| ATC | S02AA | Antiinfectives | ATC1-4 | | gentamicin |
| ATC | C05AA | Corticosteroids | ATC1-4 | | betamethasone |
| ATC | S03BA | Corticosteroids | ATC1-4 | | betamethasone |
| ATC | S02BA | Corticosteroids | ATC1-4 | | betamethasone |
| ATC | R01AD | Corticosteroids | ATC1-4 | | betamethasone |
| ATC | A07EA | Corticosteroids acting locally | ATC1-4 | | betamethasone |
| ATC | S01BA | Corticosteroids, plain | ATC1-4 | | betamethasone |
| ATC | D07AC | Corticosteroids, potent (group III) | ATC1-4 | | betamethasone |
| ATC | D07XC | Corticosteroids, potent, other combinations | ATC1-4 | | betamethasone |
| ATC | S01CB | Corticosteroids/antiinfectives/mydriatics in combination | ATC1-4 | | betamethasone |
| ATC | R03BA | Glucocorticoids | ATC1-4 | | betamethasone |
| ATC | H02AB | Glucocorticoids | ATC1-4 | | betamethasone |
| ATC | J01GB | Other aminoglycosides | ATC1-4 | | gentamicin |
| ATC | D06AX | Other antibiotics for topical use | ATC1-4 | | gentamicin |
| FDASPL | D000617 | Aminoglycosides | CHEM | has_chemical_structure | gentamicin |
| FDASPL | N0000175477 | Aminoglycoside Antibacterial | EPC | has_epc | gentamicin |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | betamethasone |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | betamethasone |
| MEDRT | D001623 | Betamethasone | CHEM | has_ingredient | betamethasone |
| MEDRT | D005839 | Gentamicins | CHEM | has_ingredient | gentamicin |
| MEDRT | D001850 | Bone Diseases, Infectious | DISEASE | may_treat | gentamicin |
| MEDRT | D002494 | Central Nervous System Infections | DISEASE | may_treat | gentamicin |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | betamethasone |
| MEDRT | D012628 | Dermatitis, Seborrheic | DISEASE | may_treat | betamethasone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | betamethasone |
| MEDRT | D004696 | Endocarditis | DISEASE | may_treat | gentamicin |
| MEDRT | D004697 | Endocarditis, Bacterial | DISEASE | may_prevent | gentamicin |
| MEDRT | D004927 | Escherichia coli Infections | DISEASE | may_treat | gentamicin |
| MEDRT | D015818 | Eye Infections, Bacterial | DISEASE | may_treat | gentamicin |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | gentamicin |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | betamethasone |
| MEDRT | D007710 | Klebsiella Infections | DISEASE | may_treat | gentamicin |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | betamethasone |
| MEDRT | D014395 | Peritonitis, Tuberculous | DISEASE | may_treat | gentamicin |
| MEDRT | D011512 | Proteus Infections | DISEASE | may_treat | gentamicin |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | betamethasone |
| MEDRT | D011552 | Pseudomonas Infections | DISEASE | may_treat | gentamicin |
| MEDRT | D011565 | Psoriasis | DISEASE | may_treat | betamethasone |
| MEDRT | D016553 | Purpura, Thrombocytopenic, Idiopathic | DISEASE | ci_with | betamethasone |
| MEDRT | D012141 | Respiratory Tract Infections | DISEASE | may_treat | gentamicin |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D018805 | Sepsis | DISEASE | may_treat | gentamicin |
| MEDRT | D016868 | Serratia Infections | DISEASE | may_treat | gentamicin |
| MEDRT | D017192 | Skin Diseases, Bacterial | DISEASE | may_treat | gentamicin |
| MEDRT | D018461 | Soft Tissue Infections | DISEASE | may_treat | gentamicin |
| MEDRT | D013203 | Staphylococcal Infections | DISEASE | may_treat | gentamicin |
| MEDRT | D014552 | Urinary Tract Infections | DISEASE | may_treat | gentamicin |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | betamethasone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | betamethasone |
| MEDRT | N0000000150 | Protein Synthesis Inhibitors | MOA | has_moa | gentamicin |
| MEDRT | N0000008297 | Antipruritic Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | betamethasone |
| MEDRT | N0000008476 | Decreased Cell Membrane Integrity | PE | has_pe | gentamicin |
| MEDRT | N0000009928 | Decreased Cellular Migration | PE | has_pe | betamethasone |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | betamethasone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008700 | Decreased Lysosomal Function | PE | has_pe | betamethasone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | gentamicin |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | betamethasone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | betamethasone |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | betamethasone |
Properties#
Category, Property, Value table| Category | Property | Value |
|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | RXNAV_VET_DRUG | US |
| ATTRIBUTES | VET_DRUG | US |
| CODES | ANADA | ANADA200416 |
| NAMES | Prescribable Synonym | gentamicin sulfate 0.057 % / betamethasone valerate 0.0284 % Topical Spray |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |